培美替尼有国产吗？培美替尼靶向药纳入医保了吗？

Recently, the European Commission has approved pemetinib for the treatment of cholangiocarcinoma. As early as April 2020, pemetinib has been approved by the US FDA for the treatment of patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion or rearrangement. Pemetinib was also approved by Japan's MHLW in March 2021. It is the first and only targeted inhibitor approved for the treatment of cholangiocarcinoma in the European Union, the United States, and Japan. This EU approval is an important milestone. It is the first time in more than a decade that the EU has proposed a new treatment option for patients with cholangiocarcinoma with FGFR2 fusion or rearrangement.

The recommended dose of pemetinib is 13.5 mg orally daily for 14 days, followed by 7 days off in a 21-day cycle. Continue treatment until disease progression or unacceptable toxicity. Swallow the tablets whole, with or without food. Common side effects are diarrhea, nausea, change in taste, vomiting, loss of appetite, weight loss, constipation, stomach pain, mouth sores, dry mouth and/or dry skin; decreased urine output; or rapid heartbeat.

Is pemetinib produced in China? Is the targeted drug pemetinib included in medical insurance? It is a pity that pemetinib has not been approved for marketing in China. Drugs that are not on the market have no way to enter the national medical insurance. Patients who want to use this drug have only one way to purchase drugs abroad. However, the manpower, material and financial resources consumed by purchasing drugs overseas are far beyond imagination, which gives many patients a headache. However, according to Medical Companion Travel, the version of pemetinib has been well received by many patients. The specification is 13.5 mg x 14 tablets and the price is around $341,175. Compared with it, it is more suitable for patients to use for a long time and is of high quality and low price. Due to the fluctuation of the exchange rate, which causes the price to rise and fall, the specific price is not very accurate for the time being. For more information about pemetinib, please contact Medical Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.